The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Cancer Screening Tests-Global Market Insights and Sales Trends 2024
Synopsis
The global Cancer Screening Tests market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Cancer Screening Tests in various end use industries. The expanding demands from the Hospital, Clinic, Lab and Other, are propelling Cancer Screening Tests market. Physical Exam, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Imaging Tests segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for Cancer Screening Tests market, driven by demand from China, the second largest economy with some signs of stabilising, the Cancer Screening Tests market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Cancer Screening Tests, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Cancer Screening Tests market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Cancer Screening Tests market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Cancer Screening Tests sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Cancer Screening Tests covered in this report include Hologic, Siemens, GRAIL, Carestream Health, Philips, Shimadzu, Canon Medical Systems, Hitachi and Esaote, etc.
The global Cancer Screening Tests market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Hologic
Siemens
GRAIL
Carestream Health
Philips
Shimadzu
Canon Medical Systems
Hitachi
Esaote
Agilent Technologies
Abbott
Beckman Coulter
QIAGEN
R-Biopharm
Sysmex
Thrive Early Early Detection
Guardant Health
Global Cancer Screening Tests market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Cancer Screening Tests market, Segment by Type:
Physical Exam
Imaging Tests
Genetic Tests
Other
Global Cancer Screening Tests market, by Application
Hospital
Clinic
Lab
Other
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Cancer Screening Tests companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
The global Cancer Screening Tests market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Cancer Screening Tests in various end use industries. The expanding demands from the Hospital, Clinic, Lab and Other, are propelling Cancer Screening Tests market. Physical Exam, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Imaging Tests segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for Cancer Screening Tests market, driven by demand from China, the second largest economy with some signs of stabilising, the Cancer Screening Tests market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Cancer Screening Tests, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Cancer Screening Tests market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Cancer Screening Tests market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Cancer Screening Tests sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Cancer Screening Tests covered in this report include Hologic, Siemens, GRAIL, Carestream Health, Philips, Shimadzu, Canon Medical Systems, Hitachi and Esaote, etc.
The global Cancer Screening Tests market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Hologic
Siemens
GRAIL
Carestream Health
Philips
Shimadzu
Canon Medical Systems
Hitachi
Esaote
Agilent Technologies
Abbott
Beckman Coulter
QIAGEN
R-Biopharm
Sysmex
Thrive Early Early Detection
Guardant Health
Global Cancer Screening Tests market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Cancer Screening Tests market, Segment by Type:
Physical Exam
Imaging Tests
Genetic Tests
Other
Global Cancer Screening Tests market, by Application
Hospital
Clinic
Lab
Other
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Cancer Screening Tests companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Cancer Screening Tests
1.1 Cancer Screening Tests Market Overview
1.1.1 Cancer Screening Tests Product Scope
1.1.2 Cancer Screening Tests Market Status and Outlook
1.2 Global Cancer Screening Tests Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Cancer Screening Tests Market Size by Region (2018-2029)
1.4 Global Cancer Screening Tests Historic Market Size by Region (2018-2023)
1.5 Global Cancer Screening Tests Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Cancer Screening Tests Market Size (2018-2029)
1.6.1 North America Cancer Screening Tests Market Size (2018-2029)
1.6.2 Europe Cancer Screening Tests Market Size (2018-2029)
1.6.3 Asia-Pacific Cancer Screening Tests Market Size (2018-2029)
1.6.4 Latin America Cancer Screening Tests Market Size (2018-2029)
1.6.5 Middle East & Africa Cancer Screening Tests Market Size (2018-2029)
2 Cancer Screening Tests Market by Type
2.1 Introduction
2.1.1 Physical Exam
2.1.2 Imaging Tests
2.1.3 Genetic Tests
2.1.4 Other
2.2 Global Cancer Screening Tests Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Cancer Screening Tests Historic Market Size by Type (2018-2023)
2.2.2 Global Cancer Screening Tests Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Cancer Screening Tests Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Cancer Screening Tests Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Cancer Screening Tests Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Cancer Screening Tests Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Cancer Screening Tests Revenue Breakdown by Type (2018-2029)
3 Cancer Screening Tests Market Overview by Application
3.1 Introduction
3.1.1 Hospital
3.1.2 Clinic
3.1.3 Lab
3.1.4 Other
3.2 Global Cancer Screening Tests Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Cancer Screening Tests Historic Market Size by Application (2018-2023)
3.2.2 Global Cancer Screening Tests Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Cancer Screening Tests Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Cancer Screening Tests Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Cancer Screening Tests Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Cancer Screening Tests Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Cancer Screening Tests Revenue Breakdown by Application (2018-2029)
4 Cancer Screening Tests Competition Analysis by Players
4.1 Global Cancer Screening Tests Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Cancer Screening Tests as of 2022)
4.3 Date of Key Players Enter into Cancer Screening Tests Market
4.4 Global Top Players Cancer Screening Tests Headquarters and Area Served
4.5 Key Players Cancer Screening Tests Product Solution and Service
4.6 Competitive Status
4.6.1 Cancer Screening Tests Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Hologic
5.1.1 Hologic Profile
5.1.2 Hologic Main Business
5.1.3 Hologic Cancer Screening Tests Products, Services and Solutions
5.1.4 Hologic Cancer Screening Tests Revenue (US$ Million) & (2018-2023)
5.1.5 Hologic Recent Developments
5.2 Siemens
5.2.1 Siemens Profile
5.2.2 Siemens Main Business
5.2.3 Siemens Cancer Screening Tests Products, Services and Solutions
5.2.4 Siemens Cancer Screening Tests Revenue (US$ Million) & (2018-2023)
5.2.5 Siemens Recent Developments
5.3 GRAIL
5.3.1 GRAIL Profile
5.3.2 GRAIL Main Business
5.3.3 GRAIL Cancer Screening Tests Products, Services and Solutions
5.3.4 GRAIL Cancer Screening Tests Revenue (US$ Million) & (2018-2023)
5.3.5 Carestream Health Recent Developments
5.4 Carestream Health
5.4.1 Carestream Health Profile
5.4.2 Carestream Health Main Business
5.4.3 Carestream Health Cancer Screening Tests Products, Services and Solutions
5.4.4 Carestream Health Cancer Screening Tests Revenue (US$ Million) & (2018-2023)
5.4.5 Carestream Health Recent Developments
5.5 Philips
5.5.1 Philips Profile
5.5.2 Philips Main Business
5.5.3 Philips Cancer Screening Tests Products, Services and Solutions
5.5.4 Philips Cancer Screening Tests Revenue (US$ Million) & (2018-2023)
5.5.5 Philips Recent Developments
5.6 Shimadzu
5.6.1 Shimadzu Profile
5.6.2 Shimadzu Main Business
5.6.3 Shimadzu Cancer Screening Tests Products, Services and Solutions
5.6.4 Shimadzu Cancer Screening Tests Revenue (US$ Million) & (2018-2023)
5.6.5 Shimadzu Recent Developments
5.7 Canon Medical Systems
5.7.1 Canon Medical Systems Profile
5.7.2 Canon Medical Systems Main Business
5.7.3 Canon Medical Systems Cancer Screening Tests Products, Services and Solutions
5.7.4 Canon Medical Systems Cancer Screening Tests Revenue (US$ Million) & (2018-2023)
5.7.5 Canon Medical Systems Recent Developments
5.8 Hitachi
5.8.1 Hitachi Profile
5.8.2 Hitachi Main Business
5.8.3 Hitachi Cancer Screening Tests Products, Services and Solutions
5.8.4 Hitachi Cancer Screening Tests Revenue (US$ Million) & (2018-2023)
5.8.5 Hitachi Recent Developments
5.9 Esaote
5.9.1 Esaote Profile
5.9.2 Esaote Main Business
5.9.3 Esaote Cancer Screening Tests Products, Services and Solutions
5.9.4 Esaote Cancer Screening Tests Revenue (US$ Million) & (2018-2023)
5.9.5 Esaote Recent Developments
5.10 Agilent Technologies
5.10.1 Agilent Technologies Profile
5.10.2 Agilent Technologies Main Business
5.10.3 Agilent Technologies Cancer Screening Tests Products, Services and Solutions
5.10.4 Agilent Technologies Cancer Screening Tests Revenue (US$ Million) & (2018-2023)
5.10.5 Agilent Technologies Recent Developments
5.11 Abbott
5.11.1 Abbott Profile
5.11.2 Abbott Main Business
5.11.3 Abbott Cancer Screening Tests Products, Services and Solutions
5.11.4 Abbott Cancer Screening Tests Revenue (US$ Million) & (2018-2023)
5.11.5 Abbott Recent Developments
5.12 Beckman Coulter
5.12.1 Beckman Coulter Profile
5.12.2 Beckman Coulter Main Business
5.12.3 Beckman Coulter Cancer Screening Tests Products, Services and Solutions
5.12.4 Beckman Coulter Cancer Screening Tests Revenue (US$ Million) & (2018-2023)
5.12.5 Beckman Coulter Recent Developments
5.13 QIAGEN
5.13.1 QIAGEN Profile
5.13.2 QIAGEN Main Business
5.13.3 QIAGEN Cancer Screening Tests Products, Services and Solutions
5.13.4 QIAGEN Cancer Screening Tests Revenue (US$ Million) & (2018-2023)
5.13.5 QIAGEN Recent Developments
5.14 R-Biopharm
5.14.1 R-Biopharm Profile
5.14.2 R-Biopharm Main Business
5.14.3 R-Biopharm Cancer Screening Tests Products, Services and Solutions
5.14.4 R-Biopharm Cancer Screening Tests Revenue (US$ Million) & (2018-2023)
5.14.5 R-Biopharm Recent Developments
5.15 Sysmex
5.15.1 Sysmex Profile
5.15.2 Sysmex Main Business
5.15.3 Sysmex Cancer Screening Tests Products, Services and Solutions
5.15.4 Sysmex Cancer Screening Tests Revenue (US$ Million) & (2018-2023)
5.15.5 Sysmex Recent Developments
5.16 Thrive Early Early Detection
5.16.1 Thrive Early Early Detection Profile
5.16.2 Thrive Early Early Detection Main Business
5.16.3 Thrive Early Early Detection Cancer Screening Tests Products, Services and Solutions
5.16.4 Thrive Early Early Detection Cancer Screening Tests Revenue (US$ Million) & (2018-2023)
5.16.5 Thrive Early Early Detection Recent Developments
5.17 Guardant Health
5.17.1 Guardant Health Profile
5.17.2 Guardant Health Main Business
5.17.3 Guardant Health Cancer Screening Tests Products, Services and Solutions
5.17.4 Guardant Health Cancer Screening Tests Revenue (US$ Million) & (2018-2023)
5.17.5 Guardant Health Recent Developments
6 North America
6.1 North America Cancer Screening Tests Market Size by Country (2018-2029)
6.2 United States
6.3 Canada
7 Europe
7.1 Europe Cancer Screening Tests Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Cancer Screening Tests Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Cancer Screening Tests Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Cancer Screening Tests Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Cancer Screening Tests Market Dynamics
11.1 Cancer Screening Tests Industry Trends
11.2 Cancer Screening Tests Market Drivers
11.3 Cancer Screening Tests Market Challenges
11.4 Cancer Screening Tests Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
